Height anxiety is common among parents of children who are shorter than their peers. Most short children are short for entirely normal reasons – they have short parents, or they are destined to be average height but are developing at a slower pace than their peers. A small but important minority have an underlying condition affecting their growth that is diagnosable and treatable.
The clinical tool that distinguishes these groups is not a single height measurement but the pattern of growth over time, the height relative to parental heights, and the presence or absence of features that suggest an underlying cause. A child growing well along a low centile is almost always normal; a child who is falling through centile lines, or who is significantly shorter than both parents, warrants investigation.
Healthbooq (healthbooq.com) covers child growth and endocrine health.
What Short Stature Means
In the UK, growth charts use centile lines to show the expected range of heights for children of different ages. The 0.4th centile is two standard deviations below the mean: statistically, about 4 in every 1,000 children will be at or below this height by chance alone. Short stature is formally defined as height below the 0.4th centile.
Height below the 2nd centile (1 in 50 children) warrants monitoring; below the 0.4th centile warrants investigation. A child whose height is above the 0.4th centile but substantially below their mid-parental height target (the height expected based on average of parents' heights) also warrants assessment.
Mid-parental height calculation: for boys, add 13cm to the mother's height and average it with the father's height. For girls, subtract 13cm from the father's height and average with the mother's. The result plus or minus 8.5cm represents the expected range for a child from that family.
Growth velocity – the rate of growth over time – is more informative than a single measurement. Children should roughly track their centile from around 2-3 years. A child crossing downward through two major centile lines warrants urgent review.
Common Normal Variants
Familial short stature (FSS): the child is short because both parents are short. The child grows along a low centile throughout childhood, has a normal growth velocity, and reaches puberty at a normal age. No treatment is needed. The prognosis for final adult height is consistent with parental heights.
Constitutional delay of growth and puberty (CDGP): the child is short and late to enter puberty but growing at a normal velocity along a low centile. Bone age (X-ray of the wrist) is delayed relative to chronological age. These children eventually go through puberty and achieve adult heights appropriate for their family. A family history of 'late developers' (late puberty, late growth spurts) is strongly supportive. CDGP is much more common in boys and is the most common cause of delayed puberty.
Both FSS and CDGP require no treatment, but accurate diagnosis prevents unnecessary investigation and reassures families. In boys with CDGP who experience significant psychological distress from being shorter and less developed than peers, short courses of low-dose testosterone can be considered to initiate puberty, having no adverse effect on final height.
Pathological Causes
Growth hormone deficiency: GH is secreted by the pituitary gland and is essential for linear growth. Deficiency produces slow growth velocity, delayed bone age, and increased fat mass. It may be isolated or associated with other pituitary hormone deficiencies. Diagnosis requires provocative GH stimulation testing. Treatment with recombinant human growth hormone (NICE-approved when criteria are met) can significantly improve final adult height.
Hypothyroidism: thyroid hormone is required for normal growth. Acquired hypothyroidism (usually due to Hashimoto's thyroiditis) causes slowing of growth velocity and weight gain. It is detectable on thyroid function tests (elevated TSH, low free T4). Treatment with levothyroxine normalises growth.
Turner syndrome: affects girls only. Caused by monosomy X (45,X karyotype) or mosaic variants. Causes short stature, ovarian failure, and a characteristic phenotype. Growth hormone treatment is approved for Turner syndrome and improves adult height. All girls with unexplained short stature should have karyotype analysis.
Coeliac disease, chronic kidney disease, and other chronic illnesses can all cause poor growth as a presenting or associated feature.
Investigation
Key investigations: full blood count, CRP, ESR (chronic inflammation), renal and liver function, thyroid function (TSH, free T4), coeliac antibodies (anti-TTG IgA with total IgA), karyotype in girls, bone age X-ray (wrist), and IGF-1 (insulin-like growth factor 1, a marker of growth hormone activity that can be measured at any time of day, unlike GH itself).
If a specific diagnosis is suspected or investigation is inconclusive, referral to a paediatric endocrinologist is appropriate.
Key Takeaways
Short stature is defined as height below the 0.4th centile for age and sex on UK growth charts, or height significantly below mid-parental height target range. The two most common causes are familial short stature (FSS) and constitutional delay of growth and puberty (CDGP), both normal variants rather than pathological conditions. However, short stature can be the presenting sign of growth hormone deficiency, coeliac disease, hypothyroidism, Turner syndrome, chronic renal failure, and other conditions that require diagnosis and treatment. Plotting growth on centile charts, calculating mid-parental height, and assessing growth velocity (rather than isolated height measurements) are the key tools in assessment. NICE guideline NG39 covers the diagnosis and treatment of short stature.
